EFTA Document EFTA01461629

As of 4/2/14 3:27 pm Description Trade Date Quantity Current Price Unit Cost Market Value Current Total Cost Unrealized G/L SANGAMO BIOSCIENCES 5/28/2013 50,000.00 $ 17.51 $ 8.44 $ 875,500.00 422,214.00 $ 453,286.00 BIOGEN 2/14/2012 2,095.00 $ 308.71 $ 119.55 $ 646,747.45 250,454.95 $ 396,292.50 FOUNDATION MEDICINE 1/13/2014 25,000.00 $ 31.62 $ 27.51 $ 790,500.00 687,663.50 $ 102,836.50 GILEAD SCIENCES INC Multiple 8,100.00 $ 73.79 $ 79.41 $ 597,699.00 643,204.00 $ (45,505.00) Total Biotech $ 3,043,139.83 $ 2,294,533.85 $ 906,910.00 ARIAD PHARMACEUTICALS Multiple 16,535.00 $ 8.03 $ 17.60 $ 132,693.38 290,997.40 $ (158,304.03) CONFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e) CONFIDENTIAL DB-SDNY-0123781 SDNY_GM_00269965 EFTA01461629